INC Research Invites DIA Attendees to Join Them for Event
INC Research invites DIA attendees to join them at the DIA Innovation Theater today at 1-2 pm.
INC Research invites DIA attendees to join them at the DIA Innovation Theater today at 1-2 pm, and will feature "Organizing for Change…Lessons Learned in Preparing a Global Organization for Innovation.” This event will address the growing pressure for the industry to reduce development costs and ensure better outcomes from clinical trials. If the necessary strategic innovations are identified and drive technological and organizational changes, these pressures can be translated into opportunities. John A. Whitaker, Ph.D., Senior Vice President, Clinical Innovation and Kari Delahunty, Senior Director, Corporate Strategy will highlight key elements in delivering innovation through successful organizational change.
INC Research will also be highlighting its recent news on becoming a Global Impact Partner with the Society for Clinical Research Sites (SCRS). As part of its ongoing commitment to strengthen site relationships globally, INC Research is hosting a private reception and networking event for site investigators on Tuesday, June 17, from 6 to 9 p.m. As a , INC is broadening its relationships with sites even further in an effort to gain insights into how the industry can improve the quality and depth of support that sites receive. INC Research CEO Jamie Macdonald and COO Alistair Macdonald along with SCRS President Christine Pierre will be on-site to meet with site investigators and discuss ways to work better together. For more information on this event, interested sites should visit Booth #1313.
Unlock Commercial Growth through Data-Driven Patient and HCP Insights
May 2nd 2025Leveraging data-driven patient and healthcare provider (HCP) insights, including social drivers of health (SDOH), is essential for life sciences companies to continuously improve patient engagement and commercial success. Mark Rodgers, AVP of Commercial Analytics at Inovalon, discusses how identifying treatment milestones, assessing HCP performance, and segmenting patient populations using SDOH data can drive targeted strategies that improve healthcare outcomes and market access
Improving Relationships and Diversifying the Site Selection Process
April 17th 2025In this episode of the Applied Clinical Trials Podcast, Liz Beatty, co-founder and chief strategy officer, Inato, discusses a number of topics around site engagement including community-based sites, the role of technology in improving site/sponsor relationships, how increased operational costs are impacting the industry, and more.
FDA Approves Nipocalimab for the Treatment of Generalized Myasthenia Gravis
April 30th 2025Approval is based on results from the pivotal Vivacity-MG3 trial in which IMAAVY (nipocalimab-aahu) demonstrated superior disease control throughout 24 weeks when compared to placebo plus standard of care.
